Doctors Innovate Fund
Investing in doctor-entrepreneurs solving thorny healthtech problems
- HomeInvest in the future of medicine, with a focus on innovations founded by doctors and serial medial entrepreneurs tackling major healthcare problems
- Home~15-20 venture investments made over ~12-18 months — diversified by stage, sector, geography, lead investor
- HomeReserves ~25% to pursue follow-on opportunities in the most promising portfolio investments
- HomeInvestments sourced by a team of dedicated investing professionals, our network of handpicked Scouts, AV’s 600K+ supporters, and other AV funds
See video policy below.
Figures represent 8 funds offered during 2022 and investors and community across all Focused Funds since inception.
AV’s Doctors Innovate Fund Advantages
- HomeTeam of experienced investors with connections to medical community
- HomeNetwork of independent Scouts, sharing investment opportunities in various regions, subsectors
- HomeNetwork of 600K+ supporters who provide advice, referrals, connections
- HomeRobust support to entrepreneurs through our CEO Services
- HomeInterest and ability to support our most promising companies in follow-on rounds
Get Answers to Your Questions by Phone or Zoom
Review the topics most important to you with a team member.
Doctors Innovate Fund News
Content at the intersection of entrepreneurship, venture capital, and specific industry sectors.
- Sign Up
VC LIVE!: The OZEMPIC® Trade: How Venture Investors Weigh the Impact of GLP-1 DrugsAround the water cooler, on any news website, and in social media forums, you’re bound to find buzz about Ozempic and a new class of weight-loss drugs. Beyond being the focus of medical and cultural attention, economists and investors are weighing in on this topic. Join us for a compelling discussion that may revolutionize your investment strategy. We’ll embark on an eye-opening journey where we decode the untapped potential of early-stage ventures in the downstream economic effects of GLP-1 adoption in drugs such as Ozempic®. Our panel consists our experienced investors from our team, including Principal Grant Demeter, Partner Alim Giga, Managing Partner Ludwig Schulze, Principal Naren Ramaswamy, Managing Partner Ron Levin, and Senior Principal Meera Oak. Discover a unique investment approach that navigates the risks and seizes the opportunities in this dynamic landscape. Our strategy is not just about making investments; it’s about crafting a vision for the future.
Ossium Health: Streamlining Stem Cell TherapiesAlumni Ventures portfolio company Ossium Health is well-positioned to develop a leading solution in the global stem cell therapy market, projected to reach $31.4 billion by 2030. Powered by the world’s largest bone marrow donor bank, Ossium is leveraging an unprecedented amount of data on stem cell behavior and characteristics to develop therapies for blood, immune, and inflammatory diseases.
Enter Secure Data Room
for key fund materials
- HomeFund Information
- HomePerformance Data
- HomeInvestor Rewards
- HomeFund Policies
Meet the Team
- Fund Team
- AV Support Team
Sample AV Doctors Innovate Fund Deals
These investments, from AV's existing portfolio, are examples of the Doctors Innovate Fund's investing strategy.*
Personal, data-driven employee healthcare platform
Fertility services in tech-enabled clinics
Platform streamlining the clinical trial process
Platform automating the patient’s journey
Clinically intelligent patient intake
A more patient-friendly telemedicine company
Fermented prebiotic to restore gut health
Pediatric urgent care at a tenth of ER costs
Personalized health-tracking smart ring
Online virtual and in-person therapy service
*For illustration purposes only. These investments are not intended to suggest any level of investment returns; not necessarily indicative of investments invested by any one fund or investor. Many returns in investments result in the loss of capital invested. These investments are not available to future fund investors except potentially in certain follow-on investment options.
Access Fund Materials
- HomeFund information
- HomePerformance data
- HomeSpeak with our team
Review on your own, chat online, or speak with our team.